PT Kalbe Genexine Biologics
🇮🇩Indonesia
- Country
- 🇮🇩Indonesia
- Ownership
- Holding, Subsidiary
- Established
- 2016-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.kg-biologics.com
Clinical Trials
2
Active:0
Completed:1
Trial Phases
2 Phases
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (50.0%)Phase 3
1 (50.0%)A Study to Evaluate the Safety and Efficacy of GX-I7 in Elderly Patients With Asymptomatic or Mild Symptoms of COVID-19
- First Posted Date
- 2021-03-23
- Last Posted Date
- 2021-03-24
- Lead Sponsor
- PT Kalbe Genexine Biologics
- Target Recruit Count
- 210
- Registration Number
- NCT04810637
- Locations
- 🇮🇩
Mitra Keluarga Kelapa Gading, Jakarta Pusat, Indonesia
🇮🇩Mitra Keluarga Kemayoran, Jakarta Pusat, Indonesia
A Study of Efepoetin Alfa in Treating Anaemia Associated With Chronic Kidney Diseases Patient
Phase 3
Completed
- Conditions
- Anaemia Associated With Chronic Kidney Disease
- Interventions
- First Posted Date
- 2019-11-07
- Last Posted Date
- 2023-12-22
- Lead Sponsor
- PT Kalbe Genexine Biologics
- Target Recruit Count
- 391
- Registration Number
- NCT04155125
- Locations
- 🇦🇺
Renal Research Gosford, Gosford, New South Wales, Australia
🇦🇺Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇦🇺Launceston General Hospital, Launceston, Tasmania, Australia
News
No news found